Septic arthritis with Listeria monocytogenes during low-dose methotrexate
Related Experiment Videos
T L Jansen1, H A van Heereveld, R F Laan
1Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
Abstract:
We describe a 22-year-old female with systemic lupus erythematosus and lymphopenia, who developed septic arthritis of the right knee with Listeria monocytogenes type 1/2 A, whilst on low-dose methotrexate (MTX). So far, septic arthritis due to this microorganism has been reported in two other patients treated with low-dose MTX, one having rheumatoid arthritis and the other psoriatic arthritis. No reports exist on patients treated with other cytotoxic antirheumatic therapies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Bacterial Meningitis I: Introduction